Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06559007
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
Phase 1 Study to Evaluate PK Safety and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics Safety and Tolerability of Single Dose HRS-5041 in Healthy Caucasian Male Participants
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase 1 open-label randomized study The objective of this study is to evaluate the PK safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants
Detailed Description:
The objective of this study is to evaluate the PK safety and tolerability of orally administered single-dose HRS-5041 in healthy Caucasian male participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None